Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimsira M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Seluria Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimsira M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active components to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication as prescribed, even if feeling well or experiencing controlled blood sugar, as discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one element of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices are crucial for diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment, as suitability may be affected. Pregnant or breastfeeding individuals should consult their physician before use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimsira M 1mg/500mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Glimsira M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimsira M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not break, crush, or chew it. Glimsira M 1mg/500mg tablets should be administered with a meal.

Common Side effects of Glimsira M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimsira M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimsira M 1mg/500mg tablets with a meal.

How Glimsira M 1mg/500mg Tablet works:

Glimsira M, a 1mg/500mg tablet, unites the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimsira M 1mg/500mg Tablet with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimsira M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against these risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glimsira M 1mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimsira M 1mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. The use of Glimsira M 1mg/500mg tablets is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimsira M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimsira M 1mg/500mg Tablet :

Should you forget a Glimsira M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimsira M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimsira M 1mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimsira M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimsira M 1mg/500mg Tablets and seek immediate medical attention.
Glimsira M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimsira M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimsira M 1mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimsira M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimsira M 1mg/500mg tablets and alcohol is unsafe. Alcohol can worsen the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimsira M 1mg/500mg Tabl...
50
MRP 61
18% off